Specimens for Lung Cancer Panel Design
NCT07401797 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2026-02-10
Summary
This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.
Conditions
- Lung Nodules
Sponsors & Collaborators
-
Maverix Medical
lead INDUSTRY
Principal Investigators
-
Scott Morris, PhD · Maverix Medical
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-08-07
- Primary Completion
- 2029-12-31
- Completion
- 2029-12-31
Countries
- United States
Study Locations
More Related Trials
-
An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
NCT07182214 ·Status: RECRUITING
-
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
NCT03633006 ·Status: COMPLETED
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study
NCT06105177 ·Status: RECRUITING
-
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01139944 ·Status: COMPLETED
-
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
NCT02597738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients
NCT05023746 ·Status: COMPLETED
-
Study of Tumor Samples From Patients With Lung Cancer
NCT00900328 ·Status: COMPLETED
-
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
NCT00340847 ·Status: COMPLETED
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
NCT05250817 ·Status: COMPLETED
-
Lung EpiCheck Biomarkers Development Study
NCT06245876 ·Status: RECRUITING
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING
-
To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer
NCT05432128 ·Status: RECRUITING
-
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
NCT06816121 ·Status: RECRUITING
-
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
NCT05665504 ·Status: RECRUITING
-
Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer
NCT04187768 ·Status: COMPLETED
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
NCT05742204 ·Status: ACTIVE_NOT_RECRUITING
-
Characterization of Methylation Patterns in Lung Cancer
NCT02373917 ·Status: COMPLETED
-
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
NCT03376971 ·Status: COMPLETED ·Phase: NA
-
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
NCT05641870 ·Status: UNKNOWN
-
Detection of Lung Cancer by Plasma Lipids
NCT04287712 ·Status: COMPLETED
-
Biomarker Discovery in Lung Cancer - Malaysia
NCT06504927 ·Status: RECRUITING